Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/9993| Title: | Effect of combined treatment of thioperamide with some antiepileptic drugs on methionine-sulfoximine induced convulsions in mice |
| Authors: | Vohora, Divya Khanam, Razia Pal, Shanthi N Pillai, K K |
| Keywords: | Gabapentin;Methionine-sulfoximine;Sodium valproate;Thioperamide |
| Issue Date: | Aug-2010 |
| Publisher: | CSIR |
| Abstract: | Methionine-sulfoximine
(MSO), a convulsant is known to
increase
the activity of histamine N-methyl transferase. The effect of a selective H3
receptor agonist R- ( ) methylhistamine (RAMH) and antagonist (thioperamide,
THP) and some
antiepileptic
drugs (gabapentin and sodium valproate) have been evaluated on MSO-induced
convulsions in mice. The effect of THP was also evaluated in combination with
these antiepileptic drugs. Sodium valproate (300 mg/kg, po) and gabapentin
(400
mg/kg, po) offered protection against MSO-induced convulsions as evidenced by a
significant prolongation of latency to abnormal dorsoflexion and complete
protection against mortality within 6 h of administration. THP (15 mg/kg, ip)
alone and in combination with sub-effective doses of gabapentin (75 mg/kg, po)
and sodium valproate (75 mg/kg, po) revealed no significant differences from
the control group or either drug alone. Hence,
the
convulsant action of MSO does not appear to be mediated
via
histaminergic mechanisms. |
| Page(s): | 858-860 |
| ISSN: | 0975-1009 (Online); 0019-5189 (Print) |
| Appears in Collections: | IJEB Vol.48(08) [August 2010] |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJEB 48(8) 858-860.pdf | 59.25 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.
) methylhistamine (RAMH) and antagonist (thioperamide,
THP) and some
antiepileptic
drugs (gabapentin and sodium valproate) have been evaluated on MSO-induced
convulsions in mice. The effect of THP was also evaluated in combination with
these antiepileptic drugs. Sodium valproate (300 mg/kg, po) and gabapentin
(400
mg/kg, po) offered protection against MSO-induced convulsions as evidenced by a
significant prolongation of latency to abnormal dorsoflexion and complete
protection against mortality within 6 h of administration. THP (15 mg/kg, ip)
alone and in combination with sub-effective doses of gabapentin (75 mg/kg, po)
and sodium valproate (75 mg/kg, po) revealed no significant differences from
the control group or either drug alone. Hence,
the
convulsant action of MSO does not appear to be mediated
via
histaminergic mechanisms.